169 related articles for article (PubMed ID: 18712976)
1. hTR RNA component as a marker of cellular proliferation in oral lichen planus.
Flatharta CO; Flint S; Toner M; Mabruk M
Asian Pac J Cancer Prev; 2008; 9(2):287-90. PubMed ID: 18712976
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation.
O'Flatharta C; Leader M; Kay E; Flint SR; Toner M; Robertson W; Mabruk MJ
J Clin Pathol; 2002 Aug; 55(8):602-7. PubMed ID: 12147655
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of Bcl-2 and Ki-67 in oral lichen planus and leukoplakia with different degrees of dysplasia.
Pigatti FM; Taveira LA; Soares CT
Int J Dermatol; 2015 Feb; 54(2):150-5. PubMed ID: 25265990
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
5. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
6. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
7. Suitability/unsuitability of cell proliferation as an indicator of malignant potential in oral lichen planus: an immunohistochemical study.
Zargaran M; Jamshidi S; Eshghyar N; Moghimbeigi A
Asian Pac J Cancer Prev; 2013; 14(11):6979-83. PubMed ID: 24377636
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in oral lichen planus.
Thongprasom K; Mutirangura A; Cheerat S
J Oral Pathol Med; 1998 Sep; 27(8):395-8. PubMed ID: 9736429
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.
Acay RR; Felizzola CR; de Araújo N; de Sousa SO
Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678
[TBL] [Abstract][Full Text] [Related]
10. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
11. Foxp3 gene expression in oral lichen planus: a clinicopathological study.
Lei L; Zhan L; Tan W; Chen S; Li Y; Reynolds M
Mol Med Rep; 2014 Mar; 9(3):928-34. PubMed ID: 24469541
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of interleukin-22 and its targeting microRNAs in oral lichen planus: a preliminary study.
Shen Z; Du G; Zhou Z; Liu W; Shi L; Xu H
J Oral Pathol Med; 2016 Aug; 45(7):523-7. PubMed ID: 26711064
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of oral lichen planus associated with hepatitis C virus infection, oral lichenoid contact sensitivity reaction and idiopathic oral lichen planus.
Mega H; Jiang WW; Takagi M
Oral Dis; 2001 Sep; 7(5):296-305. PubMed ID: 12117205
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of proliferation activity in dysplastic and nondysplastic oral lichen planus through the analysis of argyrophilic nucleolar organizer regions.
Jaafari-Ashkavandi Z; Fatemi FS
J Craniofac Surg; 2013 May; 24(3):788-91. PubMed ID: 23714881
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin K expression is increased in oral lichen planus.
Siponen M; Bitu CC; Al-Samadi A; Nieminen P; Salo T
J Oral Pathol Med; 2016 Nov; 45(10):758-765. PubMed ID: 27152719
[TBL] [Abstract][Full Text] [Related]
16. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
Li B; Li N; Cheng G; Sun X; Xu X; Shi J; Li L; Chen C
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):480-4. PubMed ID: 16133023
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of toll-like receptor-mediated signalling pathways in oral lichen planus.
Sinon SH; Rich AM; Parachuru VP; Firth FA; Milne T; Seymour GJ
J Oral Pathol Med; 2016 Jan; 45(1):28-34. PubMed ID: 25865410
[TBL] [Abstract][Full Text] [Related]
18. [The role of matrix metalloproteinases and their tissue inhibitors in oral lichen planus].
Zhang WP; Chen Y; Geng N; Tian K; Bao DM; Yang MZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jul; 41(7):420-1. PubMed ID: 17067460
[TBL] [Abstract][Full Text] [Related]
19. No detection of TSH or TSHR in oral lichen planus lesions in patients with or without hypothyroidism.
Vehviläinen M; Salem A; Asghar MY; Salo T; Siponen M
Acta Odontol Scand; 2020 Jul; 78(5):337-344. PubMed ID: 32031461
[No Abstract] [Full Text] [Related]
20. p53 expression in oral lichenoid lesions and oral lichen planus.
Arreaza A; Rivera H; Correnti M
Gen Dent; 2015; 63(1):69-72. PubMed ID: 25574723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
